FTDI
First Trust Direct Indexing’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,984
| Closed | -$432K | – | 703 |
|
|
2023
Q2 | $432K | Sell |
4,984
-889
| -15% | -$77.1K | 0.05% | 452 |
|
|
2023
Q1 | $571K | Buy |
5,873
+132
| +2% | +$12.8K | 0.07% | 362 |
|
|
2022
Q4 | $594K | Buy |
5,741
+820
| +17% | +$84.9K | 0.08% | 323 |
|
|
2022
Q3 | $417K | Buy |
4,921
+91
| +2% | +$7.71K | 0.06% | 388 |
|
|
2022
Q2 | $400K | Buy |
4,830
+559
| +13% | +$46.3K | 0.06% | 397 |
|
|
2022
Q1 | $329K | Buy |
4,271
+290
| +7% | +$22.3K | 0.04% | 474 |
|
|
2021
Q4 | $352K | Buy |
3,981
+153
| +4% | +$13.5K | 0.05% | 452 |
|
|
2021
Q3 | $296K | Buy |
3,828
+874
| +30% | +$67.6K | 0.04% | 477 |
|
|
2021
Q2 | $246K | Buy |
+2,954
| New | +$246K | 0.04% | 511 |
|
|
2021
Q1 | – | Sell |
-1,849
| Closed | -$162K | – | 470 |
|
|
2020
Q4 | $162K | Buy |
+1,849
| New | +$162K | 0.04% | 391 |
|